SÖZ
ALTI
NEWS
Home
The day in news
This week
Archive
Crisis
About
EN
AZ
sözaltı
news
Finance
Finance
EN
AZ
Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14%
finance.yahoo.com
08.09.2026 19:08
2 views
Copy link
Save
Pick
Copy link
WhatsApp
Telegram
X
Reddit
Facebook
LinkedIn
Email
More
Image
Share image
Save
Copy link
Similar stories
1 outlet
Novartis’s failed trial for cholesterol drug leads to broad biopharma stock selloff
marketwatch.com
08.09.2026
Related stories
Why you shouldn’t stake your entire retirement plan on getting an inheritance
marketwatch.com · 08.09
Strive Buys $109 Million in Bitcoin, Pushes Preferred Stock Toward $1 Billion
finance.yahoo.com · 08.09
GameStop Q2 2026 earnings: profit rises, full-year outlook raised
finance.yahoo.com · 08.09
Sapporo to move some beer production from Canada to US after tariffs
bbc.co.uk · 08.09
Strategy CEO says 'never sell' was just a marketing slogan
finance.yahoo.com · 08.09
Boston Scientific misses 2026 guidance after cyberattack
finance.yahoo.com · 08.09
← Previous
Bitcoin analyst spots 2015 signal that preceded 9,800% rally
Next →
Prediction: This ETF Will Beat the SPY Through 2027 (Not the QQQ!)